Paragon Bioservices develops and commercializes oncology immunotherapies for the treatment of cancer... Read more
Paragon Bioservices develops and commercializes oncology immunotherapies for the treatment of cancer... Read more
CEO
Add
News
Jun 26, 2020
The Business Journals: Baltimore
Paragon Gene: Best in Tech 2020: Catalent's $1.2 billion acquisition of Paragon Bioservices
Oct 17, 2019
The Business Journals: Baltimore
Paragon Gene: Paragon growing quickly toward 1,000 employees after Catalent acquisition
Jul 11, 2019
Pharamceutical Technology
Paragon Bioservices: Amicus advances its gene and cell therapies for rare metabolic diseases
Jul 11, 2019
BioPharma-Reporter
Paragon Bioservices: Paragon's Maryland facility adds Passage Bio's manufacturing suite
Jul 04, 2019
BioPortfolio
Paragon Bioservices: Paragon contracted to support Amicus preclinical gene therapy program
Jul 02, 2019
StreetInsider
Press Release: Paragon Bioservices : Amicus Therapeutics and Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing
Jun 27, 2019
The Business Journals
Paragon Bioservices: Novavax selling manufacturing business to Baltimore's Paragon Bioservices
May 21, 2019
Zacks
Paragon Bioservices: Catalent Acquires Gene Therapy Leader Paragon Bioservices
Apr 24, 2019
Industrial Info Resources
Paragon Bioservices: Catalent Spends $1.2 Billion to Buy Paragon and Entry into Genetic Therapeutic Market, an Industrial Info Market Brief
Apr 18, 2019
ABF Journal
Paragon Bioservices: JPMorgan Supports Catalent Acquisition of Paragon Bioservices
Paragon Gene Competitors
1
2
3
4
5
6
7
8
9
10